Skip to content

SiriusPoint SPNT Other Specialties — Year 10

Other product segments

Casualty
0.5%+25.0%
Property Other
0.4%
A&H
0%-100%
Other
0%
Property Catastrophe
0%

Similar metrics at other companies

Arch Capital Group logo
ACGLSpecialty — Year Ten
0.1%-0.2pp
Horace Mann Educators logo
HMNSpecialty Health — Year Ten
0%
Arch Capital Group logo
ACGLMulti-line and other specialty — Year Ten
0.4%-1.0pp
Arch Capital Group logo
ACGLSpecialty — Year Nine
0%
Arch Capital Group logo
ACGLSpecialty — Year Eight
0.5%-0.2pp
CNA Financial logo
CNASpecialty — Other
$0

Other financials

Income statement

See full
Revenue$774.6M+6.5%
Net income$102.2M+65.9%
EPS (diluted)$0.82+67.3%

Balance sheet

See full
Cash & equivalents$1.0B+9.2%
Total debt$702.9M+2.2%
Total equity$2.3B+13.7%
Total assets$12.5B+1.6%

Cash flow

See full
Operating cash flow$141.9M+260%

Valuation

See full
Market cap$2.78B+25.6%
Enterprise value$2.47B+25.1%
P/E5.6×-6.5×
P/S0.9×0.0×

Profitability

See full
Net margin15.4%+8.4pp

Returns & leverage

See full
Return on equity23.1%+15.2pp
Debt / equity0.3×0.0×

Where this comes from

Reported directly by SiriusPoint in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTen.

The official record: SiriusPoint’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about SiriusPoint's other specialties — year 10.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SiriusPoint's other specialties — year 10?
SiriusPoint (SPNT) reported other specialties — year 10 of 0.1% in Q4 2025.
What does other specialties — year 10 mean?
This metric measures the financial contribution of the Other Specialties segment in the tenth year, reflecting the long-term viability of the company's specialized risk underwriting. It allows for a comprehensive assessment of how niche product lines have evolved and impacted the company's overall financial health. This metric is vital for evaluating the long-term success of the company's specialty business strategy.